Neurogene Inc (NGNE) insider trading
Every open-market stock purchase and sale by Neurogene Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $989K over the last 12 months (9 sales). No open-market buys.
- Last insider buy: Samsara BioCapital GP LLC (Insider), $517K, 23 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $989K (9 sales). Last close $24.28 on Oct 22, 2026.
Recent NGNE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 22, 2026 | Rachel McMinn (CEO) | Bought (not open market) | — |
| Jul 7, 2026 | Christine Mikail Cvijic (CFO) | Sold | $152K |
| Jul 6, 2026 | Christine Mikail Cvijic (CFO) | Sold | $21.6K |
| Jul 2, 2026 | Christine Mikail Cvijic (CFO) | Sold | $87.5K |
| Jul 2, 2026 | Christine Mikail Cvijic (CFO) | Sold | $53.9K |
| Jul 1, 2026 | Christine Mikail Cvijic (CFO) | Sold | $25.2K |
| May 6, 2026 | Christine Mikail Cvijic (CFO) | Sold | $156K |
| May 5, 2026 | Christina Shafer (C-suite exec) | Bought (not open market) | — |
| Mar 26, 2026 | Rachel McMinn (CEO) | Sold | $74K |
| Mar 26, 2026 | Christine Mikail Cvijic (CFO) | Sold | $55.3K |
| Mar 26, 2026 | Julie Jordan (C-suite exec) | Sold | $18.1K |
| Mar 13, 2026 | Stuart Cobb (C-suite exec) | Sold | $81.5K |
| Mar 13, 2026 | Stuart Cobb (C-suite exec) | Sold | $56.7K |
| Mar 13, 2026 | Christine Mikail Cvijic (CFO) | Sold | $48.7K |
| Mar 13, 2026 | Christine Mikail Cvijic (CFO) | Sold | $29.6K |
| Mar 13, 2026 | Christine Mikail Cvijic (CFO) | Sold | $5.8K |
| Mar 13, 2026 | Stuart Cobb (C-suite exec) | Sold | $3.3K |
| Feb 27, 2026 | Christine Mikail Cvijic (CFO) | Sold | $121K |
| Feb 20, 2026 | Robert Baffi (Director) | Bought (not open market) | — |
| Feb 20, 2026 | Rachel McMinn (CEO) | Bought (not open market) | — |
| Feb 20, 2026 | Rachel McMinn (CEO) | Bought (not open market) | — |
| Feb 20, 2026 | Julie Jordan (C-suite exec) | Bought (not open market) | — |
| Feb 20, 2026 | Keith Woods (Director) | Bought (not open market) | — |
| Feb 20, 2026 | Julie Jordan (C-suite exec) | Bought (not open market) | — |
| Feb 20, 2026 | Stuart Cobb (C-suite exec) | Bought (not open market) | — |
Who's trading NGNE
- Rachel McMinn, CEO: sold $74K (1 sale), last Sep 22, 2026
- Christine Mikail Cvijic, CFO: sold $756K (11 sales), last Jul 7, 2026
- Christina Shafer, C-suite exec: other filings, last May 5, 2026
- Julie Jordan, C-suite exec: sold $18.1K (1 sale), last Mar 26, 2026
- Stuart Cobb, C-suite exec: sold $141K (3 sales), last Mar 13, 2026
- Robert Baffi, Director: other filings, last Feb 20, 2026
- Cory S. Freedland, Director: other filings, last Feb 20, 2026
- Sarah B. Noonberg, Director: other filings, last Feb 20, 2026
- Rohan Palekar, Director: other filings, last Feb 20, 2026
- Keith Woods, Director: other filings, last Feb 20, 2026
Get free alerts when an insider at Neurogene Inc files a new trade →